(Q36369444)

13 August 2017

Lipoprotein(a) and cardiovascular disease in diabetic patients (English)

1 reference

13 August 2017

0 references

cardiovascular disease

1 reference

2

Lu Qi

1 reference

13 August 2017

Qibin Qi

1

1 reference

13 August 2017

1 August 2012

1 reference

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

4

1 reference

13 August 2017

397-407

1 reference

Lipoprotein(a): more interesting than ever after 50 years

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Genetic predisposition to obesity leads to increased risk of type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a) as a cardiovascular risk factor: current status

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a) and risk of type 2 diabetes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Mendelian randomization in nutritional epidemiology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a): a causal independent risk factor for coronary heart disease?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein a: where are we now?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Alcohol intake and blood pressure: a systematic review implementing a Mendelian randomization approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Mendelian randomization as an instrumental variable approach to causal inference

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Evidence mounts for a role of the kidney in lipoprotein(a) catabolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Diabetes and cardiovascular disease. The "common soil" hypothesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Mendelian randomization: nature's randomized trial in the post-genome era.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

An introduction to instrumental variables for epidemiologists.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

A cross-sectional evaluation of cardiovascular risk factors in coronary heart disease associated with Type 1 (insulin-dependent) diabetes mellitus

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Genetically elevated lipoprotein(a) and increased risk of myocardial infarction

28 June 2018

1 reference

The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up.

21 January 2018

1 reference

Lipoprotein(a) and cardiometabolic diseases: the mystery continues.

21 January 2018

1 reference

Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease

21 January 2018

1 reference

Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients

21 January 2018

1 reference

Insulin and 2-hour glucose levels are inversely related to Lp(a) concentrations controlled for LPA genotype.

21 January 2018

1 reference

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

21 January 2018

1 reference

Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects

21 January 2018

1 reference

Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Predictors of macrovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up study

21 January 2018

1 reference

A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes

21 January 2018

1 reference

An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization

21 January 2018

1 reference

Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk

21 January 2018

1 reference

Effect of troglitazone on lipoprotein(a) levels in obese subjects.

21 January 2018

1 reference

Lp(a) concentrations in NIDDM

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3488449

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

21 September 2018

1 reference

Serum lipoprotein(a) in patients with diabetes mellitus

21 January 2018

1 reference

12 December 2020

Effect of insulin administration on serum lipoprotein(a) and its phenotypes in new-onset IDDM patients

1 reference

12 December 2020

Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes

1 reference

12 December 2020

Improved metabolic control does not change plasma lipoprotein(a) levels in adolescents with type 1 diabetes mellitus

1 reference

12 December 2020

Association of lipoprotein(a) with puberty in IDDM

1 reference

12 December 2020

Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease

1 reference

12 December 2020

Apolipoprotein(a) induces monocyte chemotactic activity in human vascular endothelial cells

1 reference

12 December 2020

Genetic variants in the apolipoprotein(a) gene and coronary heart disease

1 reference

12 December 2020

Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control

1 reference

12 December 2020

Modulation of lipoprotein(a) atherogenicity by high density lipoprotein cholesterol levels in middle-aged men with symptomatic coronary artery disease and normal to moderately elevated serum cholesterol. Regression Growth Evaluation Statin Study (RE

1 reference

12 December 2020

Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus

1 reference

12 December 2020

Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum

1 reference

12 December 2020

Independent correlation between plasma lipoprotein(a) and angiographic coronary artery disease in NIDDM

1 reference

12 December 2020

Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation

1 reference

12 December 2020

Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription

1 reference

12 December 2020

Increase of lipoprotein (a) with troglitazone

1 reference

12 December 2020

Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

1 reference

12 December 2020

Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes

1 reference

12 December 2020

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

1 reference

12 December 2020

Normal lipoprotein(a) concentrations and apolipoprotein(a) isoforms in patients with insulin-dependent diabetes mellitus

1 reference

12 December 2020

Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy

1 reference

12 December 2020

Does Lipoprotein(a) Impair Endothelial Function?

1 reference

12 December 2020

Lipoprotein(a) is an independent risk factor for coronary artery disease in NIDDM patients in South India

1 reference

12 December 2020

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

1 reference

12 December 2020

Plasma Lipoprotein(a) Levels Are Not Influenced by Glycemic Control in Type 1 Diabetes

1 reference

12 December 2020

Polymorphism of apolipoprotein E, lipoprotein(a), and other lipoproteins in children with type I diabetes

1 reference

12 December 2020

Lipoprotein (a) and vascular disease in diabetic patients

1 reference

12 December 2020

Lipoprotein(a) as a Predictor of Cardiovascular Disease in a Prospectively Followed Cohort of Patients With Type 1 Diabetes

1 reference

12 December 2020

Troglitazone's effect on lipoprotein(a) levels

1 reference

12 December 2020

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control

1 reference

12 December 2020

Identifiers

DOI

10.2217/CLP.12.46

1 reference

13 August 2017

1 reference

13 August 2017

1 reference

PMCID

3488449